Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Using time-lapse maps, we visualized the dynamics of schizophrenia progression, revealing spreading cortical changes that depend on the type of antipsychotic treatment. Dynamic, 4-dimensional models of disease progression were created from 4 repeated high-resolution brain magnetic resonance imaging scans of 36 first-episode schizophrenia patients (30 men/6 women; mean age: 24.2 +/- 5.1 SD years) randomized to haloperidol (HAL) (n = 15) or olanzapine (OLZ) treatment (n = 21), imaged at baseline, 3, 6, and 12 months (144 scans). Based on surface-based cortical models and point-by-point measures of gray matter volume, we generated time-lapse maps for each treatment. Disease trajectories differed for atypical versus typical neuroleptic drugs. A rapidly advancing parietal-to-frontal deficit trajectory, in HAL-treated patients, mirrored normal cortical maturation but greatly intensified. The disease trajectory advanced even after symptom normalization, involving the frontal cortex within 12 months with typical drug treatment. Areas with fastest tissue loss shifted anteriorly in the first year of psychosis. This trajectory was not seen with OLZ. Whether this association reflects either reduced neurotoxicity or neuroprotection cannot be addressed with neuroimaging; changes may relate to glial rather than neural components. These maps revise current models of schizophrenia progression; due to power limitations, the findings require confirmation in a sample large enough to model group x time interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric permutation tests for functional neuroimaging: A primer with examples
Nichols, T. E., & Holmes, A. P. (2002) · Human Brain Mapping · doi:10.1002/hbm.1058 · Cited by 6,256
Dynamic mapping of human cortical development during childhood through early adulthood
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., Herman, D. H., Clasen, L. S., Toga, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402680101 · Cited by 5,604 · cited 4×
“Instead, we opted to show the associated P value for the effect of group difference at each time point, as in prior work modeling gray matter trajectories in development (Gogtay et al. 2004) and Alzheimer's disease (Thompson et al. 2003).”
InfluentialSelf-citationMapping cortical change across the human life span
Sowell, E. R., Peterson, B. S., Thompson, P. M., Welcome, S. E., Henkenius, A. L., & Toga, A. W. (2003) · Nature Neuroscience · doi:10.1038/nn1008 · Cited by 2,328 · cited 2×
“…(including occipital) and limbic regions, suggesting that the treatment is not entirely protective , as these changes are regionally much higher than would be predicted to occur normally, based on large crosssectional studies of healthy subjects (Sowell et al. 2003; N = 176 subjects, aged 7--87).”
Self-citationEdgington, E., Edgington, E., & Onghena, P. (2007) · doi:10.1201/9781420011814 · Cited by 2,030
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132 · cited 2×
“2004) and Alzheimer’s disease (Thompson et al. 2003).”
Self-citationThompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812
Self-citationMcGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.790 · Cited by 556 · cited 1×
“8); most of the improvement occurred in the first 3 months (as in McGlashan et al. 2006).”
Self-citationGur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540 · cited 4×
“typical antipsychotics, frontal gray matter reduction is correlated with the dose (Gur et al. 1998), and chronic HAL, but not OLZ, administration induces oxidative damage in the rat brain”
InfluentialKeshavan, M. S., Anderson, S., & Pettergrew, J. W. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90009-4 · Cited by 525
Hof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00237-3 · Cited by 433
Cited by
van Erp, T. G. M., Walton, E., Hibar, D. P., Schmaal, L., Jiang, W., Glahn, D. C., Pearlson, G. D., Yao, N., Fukunaga, M., Hashimoto, R., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.023 · Cited by 934
Self-citationChanges in Cortical Thickness During the Course of Illness in Schizophrenia
van Haren, N. E. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.88 · Cited by 378
Gogtay, N., & Thompson, P. M. (2010) · Brain and Cognition · doi:10.1016/j.bandc.2009.08.009 · Cited by 347
Self-citationDiffusion Imaging, White Matter, and Psychopathology
Thomason, M. E., & Thompson, P. M. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032210-104507 · Cited by 305
Self-citationVoxelwise genome-wide association study (vGWAS)
Stein, J. L., Hua, X., Lee, S., Ho, A. J., Leow, A. D., Toga, A. W., Saykin, A. J., Shen, L., Foroud, T., Pankratz, N., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.032 · Cited by 270
Self-citationLocal cortical surface complexity maps from spherical harmonic reconstructions
Yotter, R. A., Nenadic, I., Ziegler, G., Thompson, P. M., & Gaser, C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.007 · Cited by 241
Self-citationVernon, A. C., Natesan, S., Modo, M., & Kapur, S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.010 · Cited by 173
Mapping connectivity in the developing brain
Dennis, E. L., & Thompson, P. M. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.05.007 · Cited by 79
Self-citationRitsner, M. S., Miodownik, C., Ratner, Y., Shleifer, T., Mar, M., Pintov, L., & Lerner, V. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05324gre · Cited by 74
Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats
Nasrallah, H. A., Hopkins, T., & Pixley, S. K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.075 · Cited by 52
Metadata
- Authors
- Thompson, P. M., Bartzokis, G., Hayashi, K. M., Klunder, A. D., Lu, P. H., Edwards, N., Hong, M. S., Yu, M., Geaga, J. A., Toga, A. W., Charles, C., Perkins, D. O., McEvoy, J., Hamer, R. M., Tohen, M., Tollefson, G. D., Lieberman, J. A., & the HGDH Study Group
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-08
- Volume
- 19
- Issue
- 5
- Pages
- 1107-1123
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2143808047
- Cited by
- 113
- References
- 15
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.